Avidity Partners Management LP Astrazeneca PLC Transaction History

Avidity Partners Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $3.01 Million - $3.64 Million	45,000 Added 28.13%	205,000 $16 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $9.76 Million - $11.1 Million	160,000 New	160,000 $10.8 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $34.5 Million - $44.9 Million	636,800 Added 113.07%	1,200,000 $81.4 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $156 Million - $399 Million	-2,935,800 Reduced 83.9%	563,200 $30.9 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $11.9 Million - $14.3 Million	-201,000 Reduced 5.43%	3,499,000 $231 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $46.4 Million - $55.9 Million	832,800 Added 29.05%	3,700,000 $245 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $78.6 Million - $92.9 Million	1,455,200 Added 103.06%	2,867,200 $167 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $78.5 Million - $85.8 Million	1,412,000 New	1,412,000 $84.8 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $177 Million - $220 Million	-3,650,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $63.7 Million - $73.5 Million	1,350,500 Added 58.72%	3,650,500 $182 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $112 Million - $133 Million	2,300,000 New	2,300,000 $115 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $17.3 Million - $19.9 Million	-325,990 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $14.1 Million - $18 Million	325,990 New	325,990 $17.2 Million

1,417

510M

9.82M

3.14M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.